Hologic, Inc(NASDAQ:HOLX)

Latest On Hologic, Inc (HOLX):

Updated on: March 18, 2021

Date/Time	Type	Description	Signal
2023-05-19 10:53 EST	News	Hologic receives FDA clearance for Panther Fusion to test COVID-19	N/A
2023-05-09 14:10 EST	News	iCAD, Hologic gain after update on breast cancer screening	N/A
2023-05-01 22:42 EST	News	Hologic Non-GAAP EPS of $1.06 beats by $0.18, revenue of $1.03B beats by $72.47M	N/A
2023-05-01 22:42 EST	News	Hologic, Inc. (HOLX) Q2 2023 Results - Earnings Call Transcript	N/A
2023-04-30 22:37 EST	News	Hologic Q2 2023 Earnings Preview	N/A

About Hologic, Inc (HOLX):

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of G read more...roup B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. It has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.

See Advanced Chart

General

Name Hologic, Inc
Symbol HOLX
Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees 5,814
Last Split Factor2:1
Last Split Date2008-04-03
Fiscal Year EndSeptember
IPO Date1990-06-21
Gic SectorHealth Care
Gic GroupHealth Care Equipment & Services
Gic IndustryHealth Care Equipment & Supplies
Gic SubIndustryHealth Care Equipment
Web URLhttp://www.hologic.com

Valuation

Trailing PE 13.65
Forward PE 8.54
Price/Sales (Trailing 12 Mt.) 4.15
Price/Book (Most Recent Quarter) 5.65
Enterprise Value Revenue 4.49
Enterprise Value EBITDA 9.17

Financials

Most Recent Quarter 2020-12-31
Current Year EPS Estimate $8.78
Next Year EPS Estimate $4.98
Next Quarter EPS Estimate $2.02
Profit Margin 31%
Operating Margin 42%
Return on Assets 17%
Return on Equity 50%
Revenue 4.54 billion
Earnings Per Share $5.27
Revenue Per Share $17.42
Gross Profit 2.51 billion
Quarterly Earnings Growth 89.3%

Highlights

Market Capitalization 18.52 billion
EBITDA 2.27 billion
PE Ratio 26.9
PEG Ratio 0.35
Analyst Target Price $88.85
Book Value Per Share $12.69

Share Statistics

Shares Outstanding 257.66 million
Shares Float 256 million
% Held by Insiders 57%
% Held by Institutions 96.99%
Shares Short 4.79 million
Shares Short Prior Month 3.95 million
Short Ratio 1.94
Short % of Float 3%
Short % of Shares Outstanding 2%

Technicals

Beta 1.2
52 Week High $85
52 Week Low $29.09
50 Day Moving Average 76.42
200 Day Moving Average 71.43

Dividends

Dividend Date N/A
ExDividend Date N/A
Dividend Yield 0%

ESG Rating

Rating Date 2019-01-01
ESG Score 28.6
Environment Score 2.95
Social Score 11.28
Governance Score 8.88
Controversy Level 2

Hologic, Inc (HOLX) Dividend Calendar:

Show entries

Search:

Ex-Dividend Date	Payment Date	Record Date	Declared Date	Amount
No data available in table

Showing 0 to 0 of 0 entries

Hologic, Inc (HOLX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

Show entries

Quarter Date	Report Date	Actual Revenue	Reported EPS	EPS Estimate	Deviation from Estimate
2020-12-31	2021-01-27	$1.61 billion	$2.86	$2.14	33.35%
2020-09-30	2020-11-04	$N/A	$2.07	$1.19	74.57%
2020-06-30	2020-07-29	$N/A	$0.75	$0.38	94.96%
2020-03-31	2020-04-29	$N/A	$0.57	$0.57	-0.61%
2019-12-31	2020-01-29	$850.5 million	$0.61	$0.61	0.25%
2019-09-30	2019-11-06	$865.8 million	$0.65	$0.65	0.08%
2019-06-30	2019-07-31	$852.4 million	$0.63	$0.61	2.79%
2019-03-31	2019-05-01	$818.4 million	$0.58	$0.57	2.13%
2018-12-31	2019-01-30	$830.7 million	$0.58	$0.57	1.72%
2018-09-30	2018-11-07	$813.4 million	$0.58	$0.59	-1.28%

Hologic, Inc (HOLX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:

Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares

Cash Flow:

Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures

Balance Sheet:

Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Hologic, Inc (HOLX) Chart:

Hologic, Inc (HOLX) News:

Below you will find a list of latest news for Hologic, Inc (HOLX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Hologic, Inc (HOLX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date:

Options Type:

Moneyness:

Show entries

Search:

Expiration Date	Strike	Last Price	Type	Volume	Open Interest	Implied Volatility	In the Money
2025-04-17	42.5	0	CALL	0	0	93.47	TRUE
2025-04-17	45	0	CALL	0	0	69.7	TRUE
2025-04-17	47.5	0	CALL	0	0	58.45	TRUE
2025-04-17	50	0	CALL	0	0	39.1	TRUE
2025-04-17	52.5	0	CALL	0	0	37.44	TRUE
2025-04-17	55	0	CALL	0	0	36.56	TRUE
2025-04-17	57.5	0	CALL	0	0	41.57	TRUE
2025-04-17	60	2.76	CALL	0	2	20.42	TRUE
2025-04-17	62.5	1.3	CALL	0	51	23.64	FALSE
2025-04-17	65	0.35	CALL	3	108	26.11	FALSE
2025-04-17	67.5	0.15	CALL	0	45	27.78	FALSE
2025-04-17	70	0.24	CALL	0	26	46.73	FALSE
2025-04-17	72.5	0.25	CALL	0	1	65.52	FALSE
2025-04-17	75	0.21	CALL	0	6	63.29	FALSE
2025-04-17	80	0	CALL	0	0	90.03	FALSE
2025-04-17	85	0	CALL	0	0	104.13	FALSE
2025-04-17	90	0	CALL	0	0	116.91	FALSE
2025-04-17	95	0	CALL	0	0	128.63	FALSE
2025-04-17	42.5	0	PUT	0	0	80.05	FALSE
2025-04-17	45	0.04	PUT	0	4	72.5	FALSE

Latest HOLX Trades:

Date	Shares	Price
Jun 13, 2022 7:59 PM EST	2	$68.55
Jun 13, 2022 7:59 PM EST	100	$68.55
Jun 13, 2022 7:59 PM EST	200	$68.55
Jun 13, 2022 7:59 PM EST	100	$68.545
Jun 13, 2022 7:59 PM EST	100	$68.53

Hologic, Inc (HOLX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Form Type:

Show entries

Search:

Date	Form Type	View
2020-11-06	4 (Statement of changes in beneficial ownership of securities)
2020-11-06	8-K (Current report)
2020-11-04	4 (Statement of changes in beneficial ownership of securities)
2020-11-04	4 (Statement of changes in beneficial ownership of securities)
2020-11-04	4 (Statement of changes in beneficial ownership of securities)
2020-11-04	4 (Statement of changes in beneficial ownership of securities)
2020-11-04	4 (Statement of changes in beneficial ownership of securities)
2020-11-04	4 (Statement of changes in beneficial ownership of securities)
2020-11-04	4 (Statement of changes in beneficial ownership of securities)
2020-11-04	8-K (Current report)
2020-11-02	3 (Initial statement of beneficial ownership of securities)
2020-10-15	8-K (Current report)
2020-10-06	8-K (Current report)
2020-09-28	8-K (Current report)
2020-09-23	4 (Statement of changes in beneficial ownership of securities)
2020-09-15	8-K (Current report)
2020-09-15	8-K (Current report)
2020-09-14	8-K (Current report)
2020-09-11	8-K (Current report)
2020-09-10	3 (Initial statement of beneficial ownership of securities)

Hologic, Inc (HOLX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Hologic, Inc (HOLX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 57%
Institutional Ownership: 9699%

Show entries

Search:

Transaction Date	Insider Name	Insider Title	Type	Shares Number	Shares Price	Total Transaction	Shares Held After Transaction
2020-11-04	Christiana Stamoulis	Director	Sell	11,146.00	74.00	824,804.00	39,392.00
2020-11-04	Christiana Stamoulis	Director	Buy	11,146.00	22.35	249,113.10	50,538.00
2020-11-02	John M. Griffin	General Counsel	Buy	34,716.00			130,023.00
2020-11-02	STEPHEN P MACMILLAN	Chairman, President and CEO	Buy	900,307.00			2,622,749.00
2020-11-02	Sean S. Daugherty	Group President, BSH & Surg.	Buy	17,432.00			31,939.00
2020-11-02	Kevin R Thornal	Div. President, Diagnostics	Buy	17,750.00			34,776.00
2020-11-02	Jan Verstreken	Group President, International	Buy	16,797.00			42,778.00
2020-11-02	Allison P Bebo	SVP, Human Resources	Buy	16,797.00			45,186.00
2020-11-02	Karleen Marie Oberton	Chief Financial Officer	Buy	16,941.00			51,358.00
2020-09-22	Karleen Marie Oberton	Chief Financial Officer	Buy	5,461.00	26.21	143,132.81	34,417.00
2020-09-21	Karleen Marie Oberton	Chief Financial Officer	Sell	15,000.00	62.50	937,500.00	28,956.00
2020-09-21	Karleen Marie Oberton	Chief Financial Officer	Buy	15,000.00	26.21	393,150.00	43,956.00
2020-08-03	BENJAMIN JORDAN COHN	Principal Accounting Officer	Sell	2,617.00	71.23	186,408.91	16,713.00
2020-08-03	BENJAMIN JORDAN COHN	Principal Accounting Officer	Sell	1,938.00	71.27	138,121.26	16,713.00
2020-08-03	BENJAMIN JORDAN COHN	Principal Accounting Officer	Sell	369.00	71.22	26,280.18	19,330.00
2020-08-03	BENJAMIN JORDAN COHN	Principal Accounting Officer	Buy	2,986.00	23.82	71,126.52	19,699.00
2020-06-30	Peter J. III Valenti	Division Pres., Breast Health	Sell	10,493.00	54.07	567,356.51	59,991.00
2020-06-30	Peter J. III Valenti	Division Pres., Breast Health	Buy	10,493.00	26.21	275,021.53	70,484.00
2020-05-22	SALLY CRAWFORD	Director	Sell	31,950.00	51.99	1,661,080.50	126,847.00
2020-05-22	Peter J. III Valenti	Division Pres., Breast Health	Sell	10,493.00	51.82	543,778.74	59,991.00

Hologic, Inc

(NASDAQ:HOLX)

$81.21

BUY

Latest On Hologic, Inc (HOLX):

About Hologic, Inc (HOLX):

General

Valuation

Financials

Highlights

Share Statistics

Technicals

Dividends

ESG Rating

Hologic, Inc (HOLX) Dividend Calendar:

Hologic, Inc (HOLX) Earnings History:

Hologic, Inc (HOLX) Company Financial Statements:

Income Statement:

Cash Flow:

Balance Sheet:

Hologic, Inc (HOLX) Chart:

Hologic, Inc (HOLX) News:

Hologic, Inc (HOLX) Options:

Latest HOLX Trades:

Hologic, Inc (HOLX) SEC Filings:

Hologic, Inc (HOLX) Insider Transactions: